Sign Up
OverviewAPI
Adial Pharmaceuticals has exercised warrants generating $3.5 million in gross proceeds, intending to utilize the funds for corporate, regulatory, and clinical activities linked to its Alcohol Use Disorder drug, AD04.

Ask a question